Here's What It Would Take to Make Moderna Stock a Screaming Buy

Moderna (NASDAQ: MRNA) isn't the high-flyer that it once was. Sure, the stock is still up nearly 170% year to date -- but it's also more than 40% below its high set this summer.

Don't rule out the possibility that investors could again flock to this beaten-down vaccine stock. Here's what it would take to make Moderna a screaming buy.

Image source: Getty Images.

Continue reading

Source Fool.com